FDA Inspection 1223617 — Wyeth BioPharma Division Of Wyeth Pharmaceuticals LLC
The FDA completed an inspection of Wyeth BioPharma Division Of Wyeth Pharmaceuticals LLC on Oct 13, 2023 in Andover, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 13, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Andover, MA (United States)